Generic name: bismuth subsalicylate 262.4mg; metronidazole 250mg; tetracycline hydrochloride 500mg
Dosage form: kit, tablets and capsules
Medically reviewed on November 1, 2017.
Adults: The recommended dosages are: bismuth subsalicylate, 525 mg (two 262.4 mg-chewable tablets), metronidazole, 250 mg (one 250-mg tablet), and tetracycline hydrochloride, 500 mg (one 500-mg capsule) taken four times daily (q.i.d.) for 14 days plus an H2 antagonist approved for the treatment of acute duodenal ulcer. Patients should be instructed to take the medicines at mealtimes and at bedtime. The bismuth subsalicylate tablets should be chewed and swallowed. The metronidazole tablet and tetracycline hydrochloride capsule should be swallowed whole with a full glass of water (8 ounces). Concomitantly prescribed H2 antagonist therapy should be taken as directed.
Ingestion of adequate amounts of fluid, particularly with the bedtime dose of tetracycline hydrochloride, is recommended to reduce the risk of esophageal irritation and ulceration. (See ADVERSE REACTIONS.)
Missed doses can be made up by continuing the normal dosing schedule until the medication is gone. Patients should not take double doses. If more than 4 doses are missed, the prescriber should be contacted.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Helidac (bismuth subsalicylate / metronidazole / tetracycline)
- Helidac Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 2 Reviews
- Drug class: H. pylori eradication agents